Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

NCT04457726 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
18
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

KK Women's and Children's Hospital

Collaborators